Related Experiment Video
Updated: May 2, 2026
A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse
Published on: October 24, 2017
Development and validation of a multi-modality system combining radiomics and deep learning for predicting
Juan Guo1, Yuhong Huang2, Zhiwei Zhang3
1Pingliang City Maternity and Child-care Hospital, Pingliang, China.
Introduction:
To improve the early prediction of hypertensive disorders of pregnancy (HDP) and gestational diabetes mellitus (GDM), we developed and validated an artificial intelligence (AI) model. This initiative was driven by the insufficient accuracy of current clinical tools. Our study aimed to determine whether integrating radiomics and deep learning features from first-trimester ultrasound scans could enhance predictive performance.
Methods:
A total of 213 pregnant women who underwent ultrasound at 8 weeks of gestation were enrolled. Clinical data, radiomics features, and deep learning features were collected. Imaging features were selected using LASSO regression. Four predictive models were developed: a clinical model, a radiomics model, a deep learning model, and a fusion model combining all feature types. Model performance was evaluated on an independent test set using metrics including AUC, sensitivity, specificity, calibration, and decision curve analysis.
Results:
In the training cohort, all models demonstrated excellent discriminatory ability, with the combined model achieving the highest AUC of 0.987 (95% CI: 0.9733-0.9999), followed by the DLR model (AUC = 0.985). The clinical model (AUC = 0.941) and radiomics model (AUC = 0.939) also performed well. In the test cohort, the combined model maintained superior performance with an AUC of 0.963 (95% CI: 0.9152-1.0000), significantly outperforming all single-modality models. Overall, the combined model exhibited optimal and stable predictive performance across both training and test datasets.
Discussion:
This enables accurate early prediction of HDP and GDM. This non-invasive tool supports tailored prenatal care, with potential to improve outcomes. Further validation in diverse groups is needed.
